fashion -WSS

fashion

author：focus 2025-09-28 12:08:49 - browse：85323

Palm Drive at Stanford University on March 28, 2023 — Palm Drive at the entrance to Stanford University. Brian Frank for STAT

The resignation of Marc Tessier-Lavigne as president of Stanford University following an investigation into irregularities in his past research marks more than just the startling downfall of the leader of one of the nation’s top research powerhouses. The case is likely to have broader repercussions, signaling a tipping point in an ongoing and often contentious debate about how to assign blame and credit in the increasingly collaborative world of research.

Science is a team sport. And while the lab leaders, or principal investigators, often get most of the attention for biomedical breakthroughs, they seldom run experiments. That work is left to postdoctoral researchers, graduate students, and others who peer through microscopes, labor away in mouse rooms, and spend countless hours pipetting. Instead, professors play more of a managerial role, supervising, critiquing, and offering big-picture feedback on the work that goes on in their lab.

It’s a longstanding arrangement, but one that leads to a thorny question when research is challenged: Who’s to blame? STAT put that question to Stanford faculty and students while reporting earlier this year on allegations of image manipulation and other misconduct related to research in Tessier-Lavigne’s lab, as well as researchers at other institutions. The answer varied depending on whom you asked.

Graduate students stressed that since faculty have no qualms using work done in their labs to land grants, win prizes, and build prestige, they should ultimately be accountable for problems with the science done under their supervision. Faculty generally agree, at least in principle, but are often quick to say that there are limits to how closely they can scrutinize their lab’s work, and that team science is in part based on trust. It’s an argument Tessier-Lavigne cited in his own statement about his resignation.

It’s also one he said wasn’t good enough.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Key Senate panel to consider PBM, drug pricing reform package

WSS

Kidney transplant patients stopped immunosuppressants in trial

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Live blog: Hearing on CRISPR

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Prime Medicine says its gene editing passes test in monkeys

entertainment

fashion

entertainment

Bright Health sells Medicare Advantage business to Molina

Eliminate the waiting period for sterilization covered by Medicaid

After affirmative action ruling, medical educators look to 'holistic review'

Sarepta Duchenne therapy fails to meet primary endpoint in trial

After affirmative action ruling, medical educators look to 'holistic review'

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Dobbs anniversary: the lost opportunity of abortion as health care

After Sarepta trial failure, Duchenne families brace for more debate

New air purifier tech could be key to improving indoor air quality

DeepMind touts AlphaFold's new skills as protein folding AI models face off

entertainment

Primary care physicians play key roles in Alzheimer's management

The Readout: Lenmeldy, GLP

There's no autism epidemic. It's an autism diagnosis epidemic

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Coloradans with cystic fibrosis could lose access to Trikafta

States should stop sabotaging methadone treatment reform

hotspot

entertainment

focus

knowledge